HOME >> MEDICINE >> NEWS
Rheumatoid arthritis patients caught in middle of doctors' disagreement over hand surgery

ANN ARBOR, MI More than two million Americans with rheumatoid arthritis are caught in the middle of a debate among physicians over which treatment medications or hand surgery will help their ravaged fingers and wrists most.

And a new University of Michigan Health System study finds that entrenched attitudes and lack of communication among rheumatologists and hand surgeons, and a dearth of data comparing the two strategies, are keeping the controversy going.

Only large studies evaluating the effectiveness of various hand operations, the researchers say, will quell the debate and help patients get consistent and beneficial care no matter what kind of doctor they see or where they live.

The multidisciplinary U-M research team reports its latest findings about attitudes among rheumatologists and surgeons in the current issue of the Journal of Rheumatology. They published previous attitude-related results in the Journal of Hand Surgery earlier this year, and last October they reported dramatic state-by-state variation in hand surgery rates in the journal Arthritis & Rheumatism.

"What we're finding is that rheumatoid arthritis care can vary tremendously depending on where patients live, what type of physician they're referred to, how much cross-training and interaction those physicians have with others, and what an individual doctor personally thinks of other specialties," says Amy Alderman, M.D., M.P.H., lead author of all three studies and a resident in Plastic & Reconstructive surgery at UMHS. "Since this is a debilitating, chronic condition that affects so many, it's very concerning that we don't have a consensus or communication among providers."

Alderman and her U-M colleagues -- who include a rheumatologist, a senior hand surgeon, general internists and a statistician -- surveyed nearly 1,000 doctors selected by random sampling from among the members of top rheumatology and hand surgery societies. For the October paper,
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
25-Jul-2003


Page: 1 2 3 4 5

Related medicine news :

1. Rheumatoid arthritis patients have double the risk of heart failure
2. Rheumatoid arthritis linked to excess risk of congestive heart failure
3. Rheumatoid arthritis patients at higher risk for unrecognized heart disease and cardiac sudden death
4. Rheumatoid arthritis causes increased complications and health care costs in inpatient and outpatient settings
5. ENBREL (Etanercept) Receives FDA Approval For Treatment Of Juvenile Rheumatoid Arthritis
6. Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis
7. Hopkins Researchers Develop New Therapy For Autoimmune Disorders Such As Rheumatoid Arthritis And Lupus
8. Changing Drug Delivery For Rheumatoid Arthritis Patients Increases Effectiveness, Lowers Costs
9. Immunosuppressive Treatment Is Important For Sufferers Of Rheumatoid Arthritis
10. University seeks recruits for arthritis study
11. A shallow hip socket predicts osteoarthritis of the hip

Post Your Comments:
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Parents need to take ... concussions, an expert warns. Parents must make sure ... standard, Dr. David Dodick, chair of the American Migraine ... Clinic College of Medicine in Scottsdale, Ariz. in an ... release. Any coach involved with teens sports needs ...
(Date:11/24/2014)... 24, 2014 Global electrophysiology devices ... by 2020, according to a new study by ... cardiac arrhythmias clubbed with growing global geriatric population ... Though still in the budding stage, the electrophysiology ... usage rates in the recent times, with physicians ...
(Date:11/24/2014)... Residents of retirement communities in Ohio and ... GOT TALENT, an annual online talent competition and showcase ... classic crooners, to seniors partying on a “night on ... living young. , “SENIORS GOT TALENT, while still having ... has always been about highlighting the vibrancy of being ...
(Date:11/24/2014)... Westbury, New York (PRWEB) November 24, 2014 ... recently contacted by the Family and Children's Association ... products such as soap, shampoo, mouthwash and other such ... senior citizens who are home bound, living in nursing ... are intended to greatly enhance the well being of ...
(Date:11/24/2014)... 2014 SafeHandles™ announced that they will ... Ed Begley Jr, airing via Discovery Channel. Dates and ... a passive, non-invasive, replaceable, and affordable germ protective device. ... shrinkable sleeves and adhesives to promote hand hygiene in ... core of SafeHandles is the desire to make a ...
Breaking Medicine News(10 mins):Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Jaffray Healthcare Conference in New York ... PDT . Dr. Helen Torley , President and ... The presentation will be webcast through the "Investors" section of ... will be made available for 90 days following the event. ...
(Date:11/24/2014)... (NYSE: CRY ), a leading medical device and ... today that it will participate in the upcoming 26 th ... 2014 at The New York Palace Hotel in ... of the Company,s presentation is scheduled to begin at 1:30 ... by Pat Mackin , President and Chief Executive Officer.The ...
(Date:11/24/2014)... Nov. 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, Inc. today ... in Melbourne, Australia of ... potential treatment of paroxysmal supraventricular tachycardia (PSVT).  The ... was well tolerated at single doses up to ... profile, desirable PK properties including rapid onset, and ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
Cached News: